Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Maulik, Nilanjana ^a   Engelman, Richard M ^b   Rousou, John A ^b   Flack III, Joseph E ^b   Deaton, David ^b   Das, Dipak K ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Apoptosis; Ischemia; Oxygen; Reperfusion; Signal transduction

Indexed keywords

DIMETHYLTHIOUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN TYROSINE KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 0344339188     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Flack J, Kimura Y, Engelman RM, Das DK. Preconditioning the heart by repeated stunning improves myocardial salvage. Circulation. 1991;84:III-369-III-374.
2. Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Phannacol. 1994;23:365-373.
3. Kimura Y, Iyengar J, Subramanian R, Cordis GA, Das DK. Myocardial adaptation by repeated short term ischemia reduces post-ischemic dysfunction. Basic Res Cardiol. 1992;87:128-138.
4. Asimakis GK, Inners-McBride K, Medellin G, Conti VR. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 1992;263:H887-H894.
5. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 1990;66:1133-1142.
6. Li GC, Vasquez BS, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.
7. Maulik N, Das DK. Hunting for differentially expressed mRNA species in preconditioned myocardium. Ann N Y Acad Sci. 1996;793:240-258.
8. Das DK, Maulik N, Moraru II. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia/reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol. 1995;27:181-193.
9. Yeh ETH. Life and death in the cardiovascular system. Circulation. 1997;95:782-786.
10. Maulik N, Kagan VE, Tyurin VA, Das DK. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol. 1998;274:H242-H248.
11. Maulik N, Yoshida T, Engelman RM, Deaton D, Flack JE, Rousou JA, Das DK. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Cardiol. 1998;186:139-145.
12. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
13. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7-10.
14. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med. 1998;24:869-875.
15. Maulik N, Sato M, Price BD, Das DK. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 1998;429:365-369.
16. Hokenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer XY. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
17. Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Ischemic preconditioning suppresses apoptosis by upregulating the anti-death gene, Bcl-2. Surg. Forum. 1998;49:209-211.
18. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Kisin E, Kagan VE, Maulik N, Das DK. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res. 1995;29:133-140.
19. Yoshida T, Maulik N, Engelman RM, HO Y-S, Magnenat J-L, Rousou JA, Flack JE, Deaton D, Das DK. Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation. 1997;96(pt 2):216-220.
20. Cordis GA, Maulik N, Das DK. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol. 1995;27:1645-1653.
21. Maulik N, Sato M, Price BD, Das DK. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 1998;429:365-369.
22. Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia. Cardiovasc Res. 1993;27:578-584.
23. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol. 1994;233:601-610.
24. Das DK, Prasad MR, Lu D, Jones RM. Preconditioning of heart by repeated stunning. Adaptive modification of antioxidative defense system. Cell Mol Biol. 1992;38:739-749.
25. Galang N, Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Nutrition Environ Interact. In press.
26. Maulik N, Yoshida T, Engelman RM, Rousou JA, Flack JE, Deaton D, Das DK. Oxidative stress developed during reperfusion of ischemic myocardium downregulates Bcl-2 gene and induces apoptosis and DNA laddering. Surg Forum. 1997;48:245-249.
27. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes; regulators of cell death. Blood. 1992;80:879-886.
28. Chen J, Graham SH, Chan PH, Lan J, Zhou RL, Simon RP. Bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport. 1995;6:394-398.
29. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A. 1993;90:4533-4537.
30. de Moissac D, Mustapha S, Greenberg AH, Kirshenbaum LA. Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκBα. J Biol Chem. 1998;273:23946-23951.
31. Maulik N, Watanabe M, Zu Y-L, Huang JA, Cordis GA, Schley JA, Das DK. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 1996;396:233-237.
32. Das DK. Ischemic preconditioning: Role of multiple kinases in signal amplification and modulation. Adv Organ Biol. 1998;6:101-124.
33. Maulik N, Yoshida T, Zu Y-L, Sato M, Banerjee A, Das DK. Ischemic stress adaptation of heart triggers a tyrosine kinase regulated signaling pathway. A potential role for MAPKAP Kinase 2. Am J Physiol. 1998; 275:H1857-H1864.
34. Staal FJT, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1990;87:9943-9947.
35. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells:AP-1 as secondary antioxidant-responsive factor. EMBO J. 1993;12:2005-2015.
36. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991;10:2247-2258.
37. Suzuki YJ, Mizuno M, Packer L. Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant inhibitable step. Biochem Biophys Res Commun. 1994;210:537-541.
38. Bagchi D, Das DK, Engelman RM, Prasad MR, Subramanian R. Polymorphonuclear leucocytes as potential source of free radicals in the ischemia-reperfused myocardium. Eur Heart J. 1990;11:800-813.
39. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell. 1990;62:1019-1029.